| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |